DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

TOKYO--(BUSINESS WIRE)--PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype ...

CLEVELAND and SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- Cell X Technologies, pioneers in automated cell processing solutions, and Aspen Neuroscience, Inc., dedicated to autologous regenerative medicine, ...

CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...

Cellular Origins reports that the company completed the first phase of its collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics ...

Regenerative medicine is renowned for its potential to restore or replace damaged or diseased organs by harnessing stem cells. The power of regenerative medicine will be especially valuable for ...

A shortage of US-made cells and other materials means ongoing reliance on imports to match domestic module capacity, according to CEA. Despite the gigawatts of recent domestic module manufacturing ...

CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...